Goodbye, lidocaine!
A local anesthetic is a boon — until your patient no longer needs it. Then it’s a bother, the patient suffering with numb cheeks, lips, and tongue, hours after a procedure is over. But relief may be at hand. San Diego-based Novalar Pharmaceuticals’ NV-101 could be the first local anesthetic reversal agent to hit the market. Under development since 2002, the drug is being reviewed by the FDA and news

